HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Onchocerciasis in Ecuador: evolution of chorioretinopathy after amocarzine treatment.

AbstractAIMS:
To investigate the impact of the macrofilaricidal drug, amocarzine, on the evolution of chorioretinopathy in onchocerciasis.
METHODS:
A prospective uncontrolled cohort study was performed using subjects infected with Onchocerca volvulus in a hyperendemic onchocerciasis focus in Esmeraldas Province in Ecuador. Study subjects were recruited into four cohorts in which ophthalmic and parasitological data were collected for 2, 3, 4, and 5 years respectively.
RESULTS:
Complete ophthalmic follow up was obtained for 294 individuals in the four cohorts. The incidence of retinal pigment epithelial atrophy tended to remain constant between cohorts while that of chorioretinal scarring with a greater observation period. The incidence rate of cases with new or extending chorioretinal lesions was greater with an increasing period of follow up. An association was seen between the cumulative microfilarial loads in the skin and the development of new chorioretinal lesions (p < 0.05). No relation was noted between cumulative microfilarial loads and the progression of existing disease.
CONCLUSION:
Amocarzine therapy did not prevent the natural evolution of chorioretinal disease. It was suggested that ocular microfilariae were necessary for the induction of chorioretinopathy in previously unaffected eyes and that extension of existing disease might also be related to the presence of ocular microfilariae or to other immunological mechanisms.
AuthorsP J Cooper, R Proaño, C Beltran, M Anselmi, R H Guderian
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 80 Issue 4 Pg. 337-42 (Apr 1996) ISSN: 0007-1161 [Print] England
PMID8703886 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anthelmintics
  • Piperazines
  • amocarzine
Topics
  • Adolescent
  • Adult
  • Age Distribution
  • Animals
  • Anthelmintics (therapeutic use)
  • Child
  • Child, Preschool
  • Cohort Studies
  • Ecuador (epidemiology)
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Middle Aged
  • Onchocerca volvulus
  • Onchocerciasis, Ocular (drug therapy, epidemiology, prevention & control)
  • Piperazines (therapeutic use)
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: